DE VIVO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.696
AS - Asia 1.270
EU - Europa 1.124
AF - Africa 84
SA - Sud America 56
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.232
Nazione #
US - Stati Uniti d'America 1.682
VN - Vietnam 357
CN - Cina 331
SG - Singapore 316
GB - Regno Unito 273
SE - Svezia 175
IT - Italia 146
DE - Germania 143
HK - Hong Kong 73
IN - India 66
FR - Francia 65
UA - Ucraina 57
RU - Federazione Russa 46
BR - Brasile 42
CH - Svizzera 40
IE - Irlanda 38
NL - Olanda 38
TG - Togo 35
KR - Corea 26
FI - Finlandia 24
BG - Bulgaria 22
JP - Giappone 22
JO - Giordania 21
EE - Estonia 20
ZA - Sudafrica 19
BE - Belgio 15
CI - Costa d'Avorio 15
BD - Bangladesh 10
CA - Canada 9
GR - Grecia 7
IR - Iran 7
LB - Libano 7
PL - Polonia 7
EC - Ecuador 5
ID - Indonesia 5
TW - Taiwan 5
CO - Colombia 4
MX - Messico 4
PH - Filippine 4
IQ - Iraq 3
MA - Marocco 3
NG - Nigeria 3
RO - Romania 3
SA - Arabia Saudita 3
SC - Seychelles 3
TH - Thailandia 3
ES - Italia 2
ET - Etiopia 2
MY - Malesia 2
PK - Pakistan 2
TN - Tunisia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CL - Cile 1
CM - Camerun 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.232
Città #
Southend 235
Singapore 224
Ashburn 199
Fairfield 169
Chandler 139
Woodbridge 94
Ann Arbor 89
Houston 88
San Jose 85
Seattle 79
Hanoi 71
Hong Kong 68
Wilmington 66
Hefei 60
Ho Chi Minh City 60
Santa Clara 47
Beijing 44
Princeton 44
Cambridge 42
Dublin 38
Jacksonville 37
Bern 36
Lomé 35
Boardman 33
Dong Ket 32
Nanjing 25
Turin 23
Helsinki 22
New York 22
Seoul 22
Amman 21
Padova 21
Sofia 21
Westminster 21
Lauterbourg 20
Los Angeles 20
Milan 20
Tokyo 19
Buffalo 17
Dallas 17
Munich 17
Berlin 16
Abidjan 14
Brussels 14
Bremen 13
Changsha 13
Washington 12
Bologna 11
Da Nang 9
Falkenstein 9
Haiphong 9
Saint Petersburg 9
San Diego 9
São Paulo 9
Jinan 8
London 8
Hebei 7
Shenyang 7
Bengaluru 6
Florence 6
Frankfurt am Main 6
Guangzhou 6
Hải Dương 6
Nanchang 6
Redondo Beach 6
Warsaw 6
Zhengzhou 6
Jiaxing 5
Mülheim 5
Phoenix 5
San Francisco 5
Chennai 4
Crevalcore 4
Dearborn 4
Denver 4
Des Moines 4
Haikou 4
Long Xuyen 4
Ningbo 4
Paris 4
Taiyuan 4
Wuhan 4
Zanjan 4
Abeokuta 3
Bühl 3
Council Bluffs 3
Jakarta 3
Mahé 3
Mumbai 3
Norwalk 3
Orem 3
Quito 3
Quận Ba 3
Shanghai 3
Thái Nguyên 3
Tân Tiến 3
Verona 3
Addis Ababa 2
Amboise 2
Amsterdam 2
Totale 2.789
Nome #
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia 276
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 260
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia 255
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia 242
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 232
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 218
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience 212
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. 200
BU/melphalan and auto-SCT in AML patients in first CR: a 'Gruppo Italiano Trapianto di Midollo Osseo (GITMO)' retrospective study. 194
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma. 186
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML. 175
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy. 167
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. 163
Intestinal microflora and digestive toxicity of irinotecan in mice. 161
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 161
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 157
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 153
INTERMITTENT IMATINIB (INTERIM) TREATMENT IN PH+-CML ELDERLY PATIENTS IN STABLE COMPLETE CYTOGENETIC RESPONSE 148
Resolution of a Pseudomonas aeruginosa outbreak in a hematology unit with the use of disposable sterile water filters. 140
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 121
Differences among young adults, adults and elderly chronic myeloid leukemia patients 117
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study. 94
null 81
null 76
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia 59
Erratum: Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia (Blood (2013) 121:26 (5138-5144)) 49
Totale 4.297
Categoria #
all - tutte 11.164
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.164


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 0 0 0 101
2021/2022509 56 12 27 67 41 22 5 31 16 38 113 81
2022/2023621 66 103 38 70 36 46 17 29 94 14 57 51
2023/2024204 10 22 20 29 18 67 7 9 1 5 11 5
2024/2025499 8 51 39 38 82 40 40 14 3 42 26 116
2025/20261.190 116 96 127 72 120 75 111 40 255 111 40 27
Totale 4.297